Purdue Pharma Backs Creditor Lawsuit Against Sacklers for Shifting Assets
Wall Street Journal
Creditors of the bankrupt OxyContin maker seek exclusive authority to sue its family owners for $11.5 billion.
Understanding current events through the lenses of the past and future.
Wall Street Journal
Creditors of the bankrupt OxyContin maker seek exclusive authority to sue its family owners for $11.5 billion.